Syngene International Invests $56 Million in Syngene USA to Expand Biologics Manufacturing
Syngene International Limited, a leading contract research, development, and manufacturing organization (CRDMO), has announced a significant investment to bolster its global operations. The company plans to invest up to $56 million in its wholly-owned subsidiary, Syngene USA Inc (SUSA), to facilitate the acquisition of a biologics manufacturing facility and support its operational needs. Details of…